Home > Boards > US OTC > Biotechs > Seneca Biopharma, Inc. (SNCA)

played this yesterday from 1.92-2.17 then bought back

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
rivervalley Member Profile
 
Followed By 53
Posts 5,257
Boards Moderated 0
Alias Born 05/24/11
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 11/16/2020 5:02:18 PM
Seneca Biopharma Reports 2020 Third Quarter Results PR Newswire (US) - 11/10/2020 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/10/2020 6:06:44 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 9/28/2020 4:31:30 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 9/16/2020 5:01:17 PM
Seneca Biopharma, Inc. Announces Completion of Phase II Clinical Study in China for the Treatment of Ischemic Stroke PR Newswire (US) - 9/10/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/9/2020 5:01:50 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 9/2/2020 2:29:54 PM
Letter from Seneca Biopharma's Executive Chairman PR Newswire (US) - 9/2/2020 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 8/21/2020 4:45:49 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 8/20/2020 2:35:03 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/14/2020 12:30:46 PM
Seneca Biopharma Reports 2020 Second Quarter Results PR Newswire (US) - 8/13/2020 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2020 6:04:24 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 8/10/2020 5:16:02 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/10/2020 5:14:35 PM
Seneca Biopharma, Inc. Announces Adjournment of Annual Meeting of Stockholders PR Newswire (US) - 8/10/2020 8:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 6/24/2020 4:48:29 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 6/12/2020 5:01:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/12/2020 5:00:45 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 5/29/2020 4:29:14 PM
Seneca Biopharma Announces the Closing of its $5 Million Registered Direct Offering PR Newswire (US) - 5/27/2020 11:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 5/27/2020 10:54:24 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/27/2020 10:53:22 AM
Seneca Biopharma Reports Receipt of Warrant Exercise Proceeds PR Newswire (US) - 5/22/2020 11:45:00 AM
rivervalley   Thursday, 12/14/17 07:19:51 AM
Re: None
Post # of 4834 
played this yesterday from 1.92-2.17 then bought back in on the pull back later at 2.07. Pm bid currently 2.25/2.29 ask.

Posts are my opinion only and not to be considered as investment advice to others.
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences